These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Update on obesity pharmacotherapy. Bray GA; Ryan DH Ann N Y Acad Sci; 2014 Apr; 1311():1-13. PubMed ID: 24641701 [TBL] [Abstract][Full Text] [Related]
28. Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery? Miras AD; le Roux CW Int J Obes (Lond); 2014 Mar; 38(3):325-33. PubMed ID: 24213310 [TBL] [Abstract][Full Text] [Related]
29. Answers to Clinical Questions in the Primary Care Management of People with Obesity: Pharmacologic Management. Fujioka K; Braverman-Panza J J Fam Pract; 2016 Jul; 65(7 Suppl):S16-23. PubMed ID: 27565106 [TBL] [Abstract][Full Text] [Related]
30. Pharmacological treatment of non-responders following bariatric surgery. Vinciguerra F; Romeo LM; Frittitta L; Baratta R Minerva Endocrinol (Torino); 2024 Jun; 49(2):196-204. PubMed ID: 33792233 [TBL] [Abstract][Full Text] [Related]
31. Weight loss medications--where do they fit in? Dixon JB Aust Fam Physician; 2006 Aug; 35(8):576-9. PubMed ID: 16894428 [TBL] [Abstract][Full Text] [Related]
34. Drug safety evaluation of naltrexone/bupropion for the treatment of obesity. Verpeut JL; Bello NT Expert Opin Drug Saf; 2014 Jun; 13(6):831-41. PubMed ID: 24766397 [TBL] [Abstract][Full Text] [Related]
35. Pharmacotherapy for obesity in individuals with type 2 diabetes. Chukir T; Shukla AP; Saunders KH; Aronne LJ Expert Opin Pharmacother; 2018 Feb; 19(3):223-231. PubMed ID: 29376439 [TBL] [Abstract][Full Text] [Related]
36. Prevalence of Antiobesity Treatment and Weight-Inducing Antihyperglycemic Agents Among Patients With Type 2 Diabetes in the United States. Levin A; Kaur N; Mainoo NK; Perez A Clin Ther; 2022 Mar; 44(3):e35-e44. PubMed ID: 35105470 [TBL] [Abstract][Full Text] [Related]
37. Past, Present, and Future of Pharmacologic Therapy in Obesity. RodrĂguez JE; Campbell KM Prim Care; 2016 Mar; 43(1):61-7, viii. PubMed ID: 26896200 [TBL] [Abstract][Full Text] [Related]
39. CHALLENGES AND NEW DIRECTIONS IN OBESITY MANAGEMENT: LIFESTYLE MODIFICATION PROGRAMMES, PHARMACOTHERAPY AND BARIATRIC SURGERY. El Ghoch M; Fakhoury R J Popul Ther Clin Pharmacol; 2019 May; 26(2):e1-e4. PubMed ID: 31577079 [TBL] [Abstract][Full Text] [Related]
40. Past, present and future of pharmacotherapy for obesity. Benaiges D; Pedro-Botet J; Flores-Le Roux JA; Climent E; Goday A Clin Investig Arterioscler; 2017; 29(6):256-264. PubMed ID: 28935287 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]